NewAmsterdam Pharma Company N.V.NAMSNASDAQ
Loading
Interest Income Over TimeExpanding
Percentile Rank100
5Y CAGR+698.3%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

5Y CAGR
+698.3%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
32423x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$27.59M+63.5%
2024$16.88M+65.2%
2023$10.22M-
2022$0.00-
2021$0.00-100.0%
2020$851.00-